Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_335a7fa4cae44e51a9f4bf828c3c45ca |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6845 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate |
2021-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f8c0ef31ef0e64f9bb39ae742e2e7a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc13fde85845b50dd9cbdd9076ab6fcf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4133cf4c30690d9cdcb90616a1f8fd6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64ca732d1c503bb204e91937c8b05938 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ba1b7162fe0ddd3c341af80d738e756 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00f01f7816bfcc837c139570434eff22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_264dffbb6b75923c30ba1f29926b2ad4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e3ecd95f547e18e582658196321c7e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f44dd6f9632090d083e779fc88c4e3d |
publicationDate |
2021-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021309706-A1 |
titleOfInvention |
Method of response prediction for bcl2 family protein targeting drug |
abstract |
Provided are a method for prediction of a response to a BCL2 family protein-targeting drug and a method for selection of a subject suitable for treatment with a BCL2 family protein-targeting drug. |
priorityDate |
2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |